Suppression of ERK signalling promotes pluripotent epiblast in the human blastocyst [mouse_ERKi_scRNAseq]

sequencing
Abstract
Day 3.25 mouse embryos were treated for 24 hours with 5µM Ulixertinib or 0.1% DMSO and collected at day 4.25 for single-cell RNA sequencing using the SMART-seq protocol from Takara.

Files

json

GEO:GSE297478

Papers

Suppression of ERK signalling promotes pluripotent epiblast in the human blastocyst
DOI:10.1038/s41467-025-61830-x